Cardiovascular health, heart failure, atherosclerosis, and cardiac research
460 articles
A completed trial tested whether seismocardiography can accurately estimate VO2max and biological age without exhaustive exercise testing.
Scientists identify GPRASP1 as a key guardian of pulmonary vascular health, opening a potential drug target for PH-HFpEF.
A specific CD40 signaling branch boosts macrophage cleanup of dead cells after MI, improving cardiac recovery in mice.
A new review examines how drugs that clear senescent cells could transform treatment of age-related cardiovascular disease.
A new review reveals how sirtuin enzymes regulate cardiac fibrosis and why targeting them could reshape heart failure treatment.
A JAMA Cardiology editorial examines how AI-powered ECG tools perform in high-risk, underserved populations where traditional diagnostics fall short.
UC San Diego scientists developed an injectable hydrogel that travels the bloodstream to reduce inflammation and regenerate damaged heart tissue.
Chronic gut inflammation in IBD drives cardiovascular disease through dysbiosis, nutrient deficits, and systemic inflammation — often without traditional warning signs.
Peter Attia answers listener questions on cardiovascular risk, metabolic health, minimum-dose strength training, dementia prevention, and NAD supplements.
New JAMA research suggests ApoB may outperform standard lipid panels for detecting CVD risk in younger populations.
A Cochrane review finds only one small RCT on surgical timing for cardiac surgery, with afternoon starts linked to lower troponin release.
New JACC research reveals gaps in emergency action plan documentation for young athletes with cardiovascular conditions at risk for sudden cardiac arrest.
